Published in Surgery Litigation and Law Weekly, November 26th, 2004
The trial involved five patient treatments using Aastrom's Tissue Repair Cells (TRCs) for the bone graft repair of severe long bone non-union fractures, and was completed at the Hospital General de l'Hospitalet, Centro Medico Teknon and Hospital de Barcelona-SCIAS.
The results to date show that Aastrom's TRCs were safe, with no adverse events reported, and that patients are exhibiting various early stages of healing....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly